HEADER OXIDOREDUCTASE 12-JUL-07 2QL8 TITLE CRYSTAL STRUCTURE OF A PUTATIVE REDOX PROTEIN (LSEI_0423) FROM TITLE 2 LACTOBACILLUS CASEI ATCC 334 AT 1.50 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE REDOX PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LACTOBACILLUS CASEI; SOURCE 3 ORGANISM_TAXID: 321967; SOURCE 4 STRAIN: ATCC 334; SOURCE 5 GENE: YP_805721.1, LSEI_0423; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 8 25-JAN-23 2QL8 1 REMARK SEQADV REVDAT 7 24-JUL-19 2QL8 1 REMARK LINK REVDAT 6 25-OCT-17 2QL8 1 REMARK REVDAT 5 18-OCT-17 2QL8 1 REMARK REVDAT 4 13-JUL-11 2QL8 1 VERSN REVDAT 3 23-MAR-11 2QL8 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 2QL8 1 VERSN REVDAT 1 24-JUL-07 2QL8 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE REDOX PROTEIN (YP_805721.1) JRNL TITL 2 FROM LACTOBACILLUS CASEI ATCC 334 AT 1.50 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 71338 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.136 REMARK 3 R VALUE (WORKING SET) : 0.135 REMARK 3 FREE R VALUE : 0.159 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3613 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4922 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.1600 REMARK 3 BIN FREE R VALUE SET COUNT : 230 REMARK 3 BIN FREE R VALUE : 0.2450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2162 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 431 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.94 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : -0.03000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.052 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.049 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.029 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.698 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.976 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.970 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2353 ; 0.017 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1561 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3209 ; 1.538 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3845 ; 0.970 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 314 ; 5.724 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;37.795 ;25.140 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 382 ;11.056 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;13.592 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 365 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2662 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 440 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 428 ; 0.222 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1655 ; 0.196 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1134 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1142 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 249 ; 0.176 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 1 ; 0.146 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 10 ; 0.226 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 40 ; 0.272 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 24 ; 0.208 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1537 ; 2.924 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 589 ; 2.043 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2378 ; 3.669 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 942 ; 4.858 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 814 ; 6.453 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 4286 ; 2.550 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 431 ; 8.828 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 3859 ; 5.326 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 3. ETHYLENE GLYCOL IS MODELED BASED ON CRYO CONDITIONS. REMARK 3 4. THE BENZOIC ACID (BEZ) MOLECULE IS ASSIGNED BASED REMARK 3 ON THE ELECTRON DENSITY AND ITS INTERACTION WITH THE PROTEIN. IT REMARK 3 COULD BE SOME RELATED COMPOUND WITH A SIMILAR STRUCTURE. REMARK 3 5. RESIDUES A0 AND B0-1 ARE DISORDERED AND WERE NOT MODELED. REMARK 4 REMARK 4 2QL8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043738. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97917, 0.97891 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 71427 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 29.761 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.1300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.51700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 2.0M (NH4)2SO4, 0.1M TRIS REMARK 280 -HCL PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.94000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 40.99500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 40.99500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 97.41000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 40.99500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 40.99500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 32.47000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 40.99500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.99500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 97.41000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 40.99500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.99500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 32.47000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 64.94000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAINS. SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY SUGGESTS THE ASSIGNMENT OF A REMARK 300 DIMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ASP A 142 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MSE A 1 CG SE CE REMARK 470 GLN A 2 CD OE1 NE2 REMARK 470 LYS A 102 CE NZ REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 GLN B 2 CB CG CD OE1 NE2 REMARK 470 GLU B 4 CG CD OE1 OE2 REMARK 470 GLU B 20 OE1 OE2 REMARK 470 LYS B 102 CD CE NZ REMARK 470 ASP B 142 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS B 124 CD LYS B 124 CE -0.152 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 105 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ASP B 139 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 8 72.25 -154.61 REMARK 500 GLU A 90 37.99 -140.73 REMARK 500 GLU A 90 43.51 -143.44 REMARK 500 GLU B 90 43.00 -143.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEZ A 143 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BEZ B 143 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 144 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 144 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 146 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 148 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 146 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 149 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 376404 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS PARTIALLY REMOVED WITH REMARK 999 TEV PROTEASE LEAVING ONLY A GLYCINE FOLLOWED BY THE REMARK 999 TARGET SEQUENCE. DBREF 2QL8 A 1 142 UNP Q03BZ3 Q03BZ3_LACC3 1 142 DBREF 2QL8 B 1 142 UNP Q03BZ3 Q03BZ3_LACC3 1 142 SEQADV 2QL8 GLY A 0 UNP Q03BZ3 EXPRESSION TAG SEQADV 2QL8 MSE A 1 UNP Q03BZ3 MET 1 MODIFIED RESIDUE SEQADV 2QL8 MSE A 39 UNP Q03BZ3 MET 39 MODIFIED RESIDUE SEQADV 2QL8 MSE A 100 UNP Q03BZ3 MET 100 MODIFIED RESIDUE SEQADV 2QL8 GLY B 0 UNP Q03BZ3 EXPRESSION TAG SEQADV 2QL8 MSE B 1 UNP Q03BZ3 MET 1 MODIFIED RESIDUE SEQADV 2QL8 MSE B 39 UNP Q03BZ3 MET 39 MODIFIED RESIDUE SEQADV 2QL8 MSE B 100 UNP Q03BZ3 MET 100 MODIFIED RESIDUE SEQRES 1 A 143 GLY MSE GLN ASP GLU ARG TRP ASN HIS PRO LEU TYR THR SEQRES 2 A 143 THR THR ALA ILE ASN ASP GLU GLU LEU GLU GLY HIS ALA SEQRES 3 A 143 TYR ILE PRO GLY GLY LEU LYS VAL GLN THR SER SER PRO SEQRES 4 A 143 MSE ASN ASP HIS PRO GLY THR ASN PRO GLU GLN LEU LEU SEQRES 5 A 143 GLY LEU SER LEU SER THR CYS LEU GLU ALA THR LEU GLU SEQRES 6 A 143 ALA VAL GLU LYS GLU HIS GLY LEU PRO HIS THR GLY ALA SEQRES 7 A 143 VAL ARG VAL LYS VAL ALA PHE ILE GLY ALA ARG ALA GLU SEQRES 8 A 143 TYR GLN PHE LEU VAL HIS ALA GLN VAL MSE VAL LYS GLY SEQRES 9 A 143 VAL ASP PHE ASP THR ALA LYS ALA PHE THR ASN GLU ILE SEQRES 10 A 143 GLU ASN ARG CYS PRO VAL SER LYS LEU LEU LYS ASN SER SEQRES 11 A 143 GLY ASN TYR THR ILE GLU THR VAL THR ASP PHE LYS ASP SEQRES 1 B 143 GLY MSE GLN ASP GLU ARG TRP ASN HIS PRO LEU TYR THR SEQRES 2 B 143 THR THR ALA ILE ASN ASP GLU GLU LEU GLU GLY HIS ALA SEQRES 3 B 143 TYR ILE PRO GLY GLY LEU LYS VAL GLN THR SER SER PRO SEQRES 4 B 143 MSE ASN ASP HIS PRO GLY THR ASN PRO GLU GLN LEU LEU SEQRES 5 B 143 GLY LEU SER LEU SER THR CYS LEU GLU ALA THR LEU GLU SEQRES 6 B 143 ALA VAL GLU LYS GLU HIS GLY LEU PRO HIS THR GLY ALA SEQRES 7 B 143 VAL ARG VAL LYS VAL ALA PHE ILE GLY ALA ARG ALA GLU SEQRES 8 B 143 TYR GLN PHE LEU VAL HIS ALA GLN VAL MSE VAL LYS GLY SEQRES 9 B 143 VAL ASP PHE ASP THR ALA LYS ALA PHE THR ASN GLU ILE SEQRES 10 B 143 GLU ASN ARG CYS PRO VAL SER LYS LEU LEU LYS ASN SER SEQRES 11 B 143 GLY ASN TYR THR ILE GLU THR VAL THR ASP PHE LYS ASP MODRES 2QL8 MSE A 1 MET SELENOMETHIONINE MODRES 2QL8 MSE A 39 MET SELENOMETHIONINE MODRES 2QL8 MSE A 100 MET SELENOMETHIONINE MODRES 2QL8 MSE B 39 MET SELENOMETHIONINE MODRES 2QL8 MSE B 100 MET SELENOMETHIONINE HET MSE A 1 5 HET MSE A 39 8 HET MSE A 100 8 HET MSE B 39 8 HET MSE B 100 8 HET BEZ A 143 9 HET EDO A 144 4 HET EDO A 145 4 HET EDO A 146 4 HET EDO A 147 4 HET EDO A 148 4 HET EDO A 149 4 HET BEZ B 143 9 HET EDO B 144 4 HET EDO B 145 4 HET EDO B 146 4 HETNAM MSE SELENOMETHIONINE HETNAM BEZ BENZOIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 5(C5 H11 N O2 SE) FORMUL 3 BEZ 2(C7 H6 O2) FORMUL 4 EDO 9(C2 H6 O2) FORMUL 14 HOH *431(H2 O) HELIX 1 1 ASP A 3 ASN A 7 5 5 HELIX 2 2 ASN A 46 HIS A 70 1 25 HELIX 3 3 ASP A 105 CYS A 120 1 16 HELIX 4 4 CYS A 120 LYS A 127 1 8 HELIX 5 5 ASP B 3 ASN B 7 5 5 HELIX 6 6 ASN B 46 HIS B 70 1 25 HELIX 7 7 ASP B 105 CYS B 120 1 16 HELIX 8 8 CYS B 120 LYS B 127 1 8 HELIX 9 9 ASN B 128 GLY B 130 5 3 SHEET 1 A 4 TYR A 11 ASN A 17 0 SHEET 2 A 4 GLY B 76 ALA B 87 -1 O VAL B 80 N ALA A 15 SHEET 3 A 4 GLU B 90 VAL B 101 -1 O GLN B 98 N ARG B 79 SHEET 4 A 4 TYR B 132 THR B 136 1 O THR B 133 N ALA B 97 SHEET 1 B 2 GLY A 23 TYR A 26 0 SHEET 2 B 2 LYS A 32 THR A 35 -1 O VAL A 33 N ALA A 25 SHEET 1 C 4 TYR A 132 THR A 136 0 SHEET 2 C 4 GLU A 90 VAL A 101 1 N ALA A 97 O THR A 133 SHEET 3 C 4 GLY A 76 ALA A 87 -1 N LYS A 81 O HIS A 96 SHEET 4 C 4 TYR B 11 ASN B 17 -1 O ALA B 15 N VAL A 80 SHEET 1 D 2 GLY B 23 TYR B 26 0 SHEET 2 D 2 LYS B 32 THR B 35 -1 O VAL B 33 N ALA B 25 LINK C MSE A 1 N GLN A 2 1555 1555 1.34 LINK C PRO A 38 N MSE A 39 1555 1555 1.34 LINK C MSE A 39 N ASN A 40 1555 1555 1.32 LINK C VAL A 99 N MSE A 100 1555 1555 1.32 LINK C MSE A 100 N VAL A 101 1555 1555 1.35 LINK C PRO B 38 N MSE B 39 1555 1555 1.32 LINK C MSE B 39 N ASN B 40 1555 1555 1.32 LINK C VAL B 99 N MSE B 100 1555 1555 1.34 LINK C MSE B 100 N VAL B 101 1555 1555 1.33 SITE 1 AC1 8 THR A 62 ALA A 65 ARG A 119 HOH A 278 SITE 2 AC1 8 HOH A 347 ALA B 89 TYR B 91 EDO B 146 SITE 1 AC2 9 ARG A 88 ALA A 89 TYR A 91 EDO A 148 SITE 2 AC2 9 EDO A 149 THR B 62 ARG B 119 HOH B 158 SITE 3 AC2 9 HOH B 294 SITE 1 AC3 4 GLN A 92 HOH A 258 ARG B 5 HOH B 341 SITE 1 AC4 9 TYR A 26 ILE A 27 PRO A 28 GLY A 29 SITE 2 AC4 9 GLY A 30 GLY A 103 EDO A 146 HOH A 273 SITE 3 AC4 9 HOH A 351 SITE 1 AC5 6 ASP A 18 TYR A 26 HIS A 70 EDO A 146 SITE 2 AC5 6 HOH A 196 HOH A 209 SITE 1 AC6 6 LYS A 32 ASP A 105 EDO A 144 EDO A 145 SITE 2 AC6 6 HOH A 196 HOH A 336 SITE 1 AC7 6 PRO A 28 GLY A 71 PRO A 73 HOH A 208 SITE 2 AC7 6 HOH A 327 HOH B 224 SITE 1 AC8 6 HOH A 154 GLY B 71 LEU B 72 PRO B 73 SITE 2 AC8 6 HOH B 178 HOH B 300 SITE 1 AC9 6 MSE A 39 PHE A 84 TYR A 91 HOH A 248 SITE 2 AC9 6 HOH A 289 BEZ B 143 SITE 1 BC1 7 CYS A 58 BEZ A 143 PRO B 38 PRO B 47 SITE 2 BC1 7 GLU B 48 PHE B 84 HOH B 296 SITE 1 BC2 7 PRO A 38 GLU A 48 PHE A 84 HOH A 279 SITE 2 BC2 7 HOH A 284 CYS B 58 BEZ B 143 CRYST1 81.990 81.990 129.880 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012197 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012197 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007699 0.00000 HETATM 1 N MSE A 1 30.740 19.701 11.113 1.00 47.11 N ANISOU 1 N MSE A 1 5876 6316 5706 -108 20 86 N HETATM 2 CA MSE A 1 30.991 19.617 9.631 1.00 47.27 C ANISOU 2 CA MSE A 1 5933 6111 5914 -100 66 21 C HETATM 3 C MSE A 1 31.526 20.975 9.130 1.00 47.93 C ANISOU 3 C MSE A 1 5983 6010 6215 14 20 18 C HETATM 4 O MSE A 1 32.747 21.133 8.967 1.00 52.13 O ANISOU 4 O MSE A 1 6195 6706 6902 -46 84 -75 O HETATM 5 CB MSE A 1 29.723 19.202 8.870 1.00 47.26 C ANISOU 5 CB MSE A 1 5849 6099 6008 -141 41 -32 C